LingZhi Xu

LingZhi Xu

Auto-generated profile, based on publicly available information

LingZhi Xu

Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
LXLing-Zhi Xu
Ling-Zhi Xu
BLBing-Qiu Li
Bing-Qiu Li
FLFangyu Li
Fangyu Li
YLYing Li
Ying Li
WQWei Qin
Wei Qin
JJJianping Jia
Jianping Jia
Background: Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia among the elderly. Excitotoxicity has been implicated as playing a dominant role in AD, especially related to the hyperactivation of excitatory neurons. Death-associated protein kinase 1 (DAPK1) is a calcium/calmodulin-dependent kinase and involved in the pathogenesis of AD, but the roles and mechanisms of DAPK1 in excitotoxicity in AD are still uncertain. Objective: We mainly explored the underlying mechanisms of DAPK1 involved in the excitotoxicity of AD and its clinical relevance. Methods: Differentiated SH-SY5Y human neuroblastoma cells, PS1 V97 L transgenic mice, and human plasma samples were used. Protein expression was assayed by immunoblotting, and intracellular calcium and neuronal damage were analyzed by flow cytometry. Plasma DAPK1 was measured by ELISA. Results: We found that DAPK1 was activated after amyloid-β oligomers (AβOs) exposure in differentiated SH-SY5Y cells. Besides, we found the phosphorylation of GluN2B subunit at Ser1303 was increased, which contributing to excitotoxicity and Ca2+ overload in SH-SY5Y cells. Inhibiting DAPK1 activity, knockdown of DAPK1 expression, and antagonizing GluN2B subunits could effectively prevent AβOs-induced activation of GluN2B subunit, Ca2+ overload, and neuronal apoptosis. Additionally, we found that DAPK1 was elevated in the brain of AD transgenic mouse and in the plasma of AD patients. Conclusion: Our finding will help to understand the mechanism of DAPK1 in the excitotoxicity in AD and provide a reference for the diagnosis and therapy of AD.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
LXLingzhi Xu
Lingzhi Xu
BLBingqiu Li
Bingqiu Li
FLFangyu Li
Fangyu Li
YZYu Zhao
Yu Zhao
MQMeina Quan
Meina Quan
JJJianping Jia
Jianping Jia
Background: Alzheimer disease (AD) is the most common neurodegenerative disorder leading to dementia in the elderly worldwide. Wnt signaling participates in multiple aspects of cellular function, and contributes to synapse formation, synaptic activity and neurogenesis in the brain, and dysfunction of Wnt signaling may aggravate the pathogenesis and progression of AD. Wnt2b has been studied in cancers or tumor‐related diseases, while the roles of Wnt2b in AD is still unknown. Wnt2b is also characterized as a mitochondria‐expressed protein which shuttles between mitochondria and the nucleus, and mitochondrial dysfunction contributes to the development and progression of the pathological process that underlies AD, especially at the early stage. This study investigated the relationship between plasma Wnt2b levels and AD, and explored the effect of Wnt2b on mitochondrial dysfunction in AD.Method: Normal cognitive (NC) and AD subjects, AD transgenic mice and in vitro model were used to investigated the roles of Wnt2b in abnormalities in canonical Wnt signaling and mitochondria in AD. RT‐qPCR, immunoblotting and immunofluorescence analysis were performed to assay canonical Wnt sign aling. Mitochondrial structure was analyzed by electron microscopy. Flow cytometry was used to examine the intracellular calcium and neuronal apoptosis.Result: In this study, we found plasma Wnt2b levels were lower in AD patients than NC subjects and positively correlated with cognitive performance (Figure 1). Similarly, Wnt2b was reduced in the hippocampus of AD mice and in vitro models (Figure 1). Next, Wnt2b overexpression and recombinant Wnt2b was used to endogenously (Figure 2) and exogenously (Figure 3) upregulate Wnt2b levels. Upregulation of Wnt2b could effectively prevent downregulation of canonical Wnt signaling, mitochondrial dysfunction in in vitro AD models. Subsequently, intracellular calcium overload and neuronal damage were ameliorated.Conclusion: Our study highlights that Wnt2b decline is associated with cognitive impairment in AD, and Our findings may advance the understanding of the importance of Wnt family in AD, and we propose that Wnt2b might be a potential diagnostic indicator and therapeutic target for AD.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
MQMeina Quan
Meina Quan
XLXinyue Li
Xinyue Li
YWYiping Wei
Yiping Wei
WWWei Wang
Wei Wang
LXLingZhi Xu
LingZhi Xu
JJJianping Jia
Jianping Jia
Background: Transgenic mouse models are important tools for studying the pathogenesis of Alzheimer’s Disease (AD) and drug development. Commonly used models are constructed from early‐onset AD mutations in the Caucasian population, and are usually overexpression or knock‐in of multiple pathogenic gene mutations. However, they are not consistent with the genetic characteristics in real world where single gene mutation occurs most of the time. Furthermore, AD transgenic mouse models have been mostly depending on a few institutions/companies and limited by intellectual property protection.Method: We systematically summarized the research progress of a transgenic mouse model based on a single gene mutation (PS1V97L) found uniquely in Chinese familial AD, as well as the underling mechanisms such as Aβ oligomers (AβO) self‐replication (figure 1). We further compared them with other single‐transgene models, and summarized the preliminary findings of several drugs targeting AβO.Result: PS1V97L transgenic mice showed age‐related AD phenotypes such as Aβ accumulation, tau phosphorylation, neurofibrillary tangles, gliosis, synaptic degeneration and cognitive impairment (figure 2). The unique characteristics of this model is the aggregation of interneuronal AβO in cortex and hippocampus, but no plaques formed up to 24 months. Other mechanisms of PS1V97L model include oxidative stress, inflammation, abnormal energy metabolism, and alterations in AD‐related signaling pathways, such as PI3K/Akt and Nrf2/ARE pathways. Several drugs including sulforaphane, honokiol, tenuifolin, isoliquiritigenin, ginsenoside, butylphthalide and oxiracetam were found effective in PS1V97L mouse model as well as rat and cell models based on AβO mechanism.Conclusion: Although carrying only one mutation, PS1V97L transgenic mouse model can mimic almost all AD pathological phenotypes, and supports AβO pathogenic hypothesis. It provides important basic and translational tool for exploring the upstream mechanisms, risk factors, and multi‐target drug development in AD.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
BLBingqiu Li
Bingqiu Li
LXLingZhi Xu
LingZhi Xu
JJJianping Jia
Jianping Jia
Background: Alzheimer’s disease (AD) is the most common form of neurodegenerative disease and most anti‐AD drugs have failed in clinical trials, hence it is urgent to find effective potential drugs against AD. DL‐3‐n‐Butylphthalide (NBP) is a compound extracted from celery seed and is a multiple‐target drug, and we have demonstrated NBP was effective for improving cognitive and global functioning in patients with subcortical vascular cognitive impairment without dementia and exhibited good safety. Even though there are several studies that have demonstrated the neuroprotective effects of NBP on cognitive impairment, and the mechanisms of NBP remains relatively unexplored.Method: Cell viabilities was observed by MTT. Apoptosis and the level of intracellular Ca2+ were examined by flow cytometry. The activation of CaMKIIα signaling was detected by western blotting and immunofluorescence.Result: In this study, we found that NBP could alleviated the increase of intracellular Ca2+ and reverse down‐regulation of Ca2+/calmodulin‐dependent protein kinase alpha (CaMKIIα) signaling, and rescue neuronal apoptosis in SH‐SY5Y cells treated by Aβ oligomers. Further, we found that these neuroprotection of NBP on neuronal damage and CaMKIIα signaling were abolished when CaMKIIα expression was knock‐downed or its activity was inhibited.Conclusion: Thus, our findings suggested that CaMKIIα signaling was required for the neuroprotective effects of NBP in AD, and provide an improved basis for elucidation of the mechanism and treatment of NBP in AD.